Home > Signaling Pathways>Neuronal Signaling>Adrenergic Receptor>Brimonidine Tartrate (UK 14304; AGN190342)
Brimonidine Tartrate (UK 14304; AGN190342)

This product is for research use only, not for human use. We do not sell to patients.

Brimonidine Tartrate (UK 14304; AGN190342)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
2g$650Check With Us
5g$1050Check With Us
10g$1575Check With Us

Cat #: V1105 CAS #: 70359-46-5 Purity ≥ 98%

Description: Brimonidine Tartrate (AGN-190342; UK14304; UK-14304; Alphagan), the tartrate salt of Brimonidine, is a highly potent and selective α-adrenergic receptor agonist with anti-hypertensive effects.

References: Andorn, A.C., M.A. Carlson, and R.C. Gilkeson, Specific [3H]UK 14,304 binding in human cortex occurs at multiple high affinity states with alpha 2-adrenergic selectivity and differing affinities for GTP. Life Sci, 1988. 43(22): p. 1805-12.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)442.22
Molecular FormulaC15H16BrN5O6
CAS No.70359-46-5
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 88 mg/mL (199 mM)r
Water: <1 mg/mLr
Ethanol: 75 mg/mL (169.6 mM)
SynonymsAGN 190342; UK 14304; UK14304; Alphagan; AGN-190342; AGN190342; UK 14,304-18; UK 14,304; UK-14304; UK-14,304-18; UK-14,308
ProtocolIn Vitro[3H]Brimonidine (UK 14304) is a full agonist at alpha 2-adrenergic receptors. [3H]Brimonidine (UK 14304) labels at least 2 specific binding sites in human brain that both have the characteristics of an alpha 2-adrenergic binding site. GTP decreases agonist binding at both of these sites, but with different potencies at each site [1-3].
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM2.2613 mL11.3066 mL22.6132 mL45.2264 mL
5mM0.4523 mL2.2613 mL4.5226 mL9.0453 mL
10mM0.2261 mL1.1307 mL2.2613 mL4.5226 mL
20mM0.1131 mL0.5653 mL1.1307 mL2.2613 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.